1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Zdunek, J. Martinez, G.V. Schleucher, J. Lycksell, P.O. Yin, Y. Nilsson, S. Shen, Y. Olivecrona, G. Wijmenga, S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 42 1872 10.1021/BI0267184 12590574 Global Structure and Dynamics of Human Apolipoprotein Cii in Complex with Micelles: Evidence for Increased Mobility of the Helix Involved in the Activation of Lipoprotein Lipase 2003 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 8921.864 APOLIPOPROTEIN C-II 1 man polymer APO-CII no no TQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE TQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample 9606 LIVER HOMO SAPIENS 469008 ESCHERICHIA COLI BL21(DE3) PET29A(+) PET29A-HAPOCII repository Initial release Version format compliance Version format compliance 1 0 2003-02-27 1 1 2011-05-08 1 2 2011-07-13 PEPTIDE OF HUMAN APOLIPOPROTEIN C-II NMR STRUCTURE OF HUMAN APOLIPOPROTEIN C-II IN THE PRESENCE OF SDS HELIX DETERMINATION METHOD: AUTHOR PROVIDED. PDBE Y PDBE 2002-11-29 REL APOC-II IS A COMPONENT OF THE VERY LOW DENSITY LIPOPROTEIN (VLDL) FUNCTIONS AS AN ACTIVATOR OF SEVERAL TRIACYLGLYCEROL LIPASES. LEAST ENERGY, LEAST RESTRAINT VIOLATION 100 68 CBCANHCBCA(CO)NHCBCACO(N) HHNCOSPIN-LOCK HCANHHCC(CO) NH1H-15N NOESY-HSQC2D NOESY1H-15N HNHA15N T115N T215N-{1H} NOE 10 MM ACETIC ACID 380 MM SDS 4.5 pH 1 atm 313 K IN ADDITION TO CLASSICAL NMR CONSTRAINTS THREE TYPES OF GLOBAL CONSTRAINTS WERE USED TO DEFINE THE GLOBAL STRUCTURE OF APO-CII IN THE APO-CII/SDS- MICELLE COMPLEX. SCRIPTS FOR THE GLOBAL STRUCTURE DETERMINATION HAVE BEEN WRITTEN AND ARE AVAILABLE UPON REQUEST. FINALLY, CNS WAS USED FOR THE FINAL MINIMIZATION. RESTRAINT MOLECULAR DYNAMICS 1 BRUNGER refinement X-PLOR3.851 structure solution XEASY structure solution SYBYL structure solution XPLOR structure solution CNS 600 Bruker DRX 500 Bruker AMX 400 Bruker DRX THR 1 n 1 THR 1 A GLN 2 n 2 GLN 2 A GLN 3 n 3 GLN 3 A PRO 4 n 4 PRO 4 A GLN 5 n 5 GLN 5 A GLN 6 n 6 GLN 6 A ASP 7 n 7 ASP 7 A GLU 8 n 8 GLU 8 A MET 9 n 9 MET 9 A PRO 10 n 10 PRO 10 A SER 11 n 11 SER 11 A PRO 12 n 12 PRO 12 A THR 13 n 13 THR 13 A PHE 14 n 14 PHE 14 A LEU 15 n 15 LEU 15 A THR 16 n 16 THR 16 A GLN 17 n 17 GLN 17 A VAL 18 n 18 VAL 18 A LYS 19 n 19 LYS 19 A GLU 20 n 20 GLU 20 A SER 21 n 21 SER 21 A LEU 22 n 22 LEU 22 A SER 23 n 23 SER 23 A SER 24 n 24 SER 24 A TYR 25 n 25 TYR 25 A TRP 26 n 26 TRP 26 A GLU 27 n 27 GLU 27 A SER 28 n 28 SER 28 A ALA 29 n 29 ALA 29 A LYS 30 n 30 LYS 30 A THR 31 n 31 THR 31 A ALA 32 n 32 ALA 32 A ALA 33 n 33 ALA 33 A GLN 34 n 34 GLN 34 A ASN 35 n 35 ASN 35 A LEU 36 n 36 LEU 36 A TYR 37 n 37 TYR 37 A GLU 38 n 38 GLU 38 A LYS 39 n 39 LYS 39 A THR 40 n 40 THR 40 A TYR 41 n 41 TYR 41 A LEU 42 n 42 LEU 42 A PRO 43 n 43 PRO 43 A ALA 44 n 44 ALA 44 A VAL 45 n 45 VAL 45 A ASP 46 n 46 ASP 46 A GLU 47 n 47 GLU 47 A LYS 48 n 48 LYS 48 A LEU 49 n 49 LEU 49 A ARG 50 n 50 ARG 50 A ASP 51 n 51 ASP 51 A LEU 52 n 52 LEU 52 A TYR 53 n 53 TYR 53 A SER 54 n 54 SER 54 A LYS 55 n 55 LYS 55 A SER 56 n 56 SER 56 A THR 57 n 57 THR 57 A ALA 58 n 58 ALA 58 A ALA 59 n 59 ALA 59 A MET 60 n 60 MET 60 A SER 61 n 61 SER 61 A THR 62 n 62 THR 62 A TYR 63 n 63 TYR 63 A THR 64 n 64 THR 64 A GLY 65 n 65 GLY 65 A ILE 66 n 66 ILE 66 A PHE 67 n 67 PHE 67 A THR 68 n 68 THR 68 A ASP 69 n 69 ASP 69 A GLN 70 n 70 GLN 70 A VAL 71 n 71 VAL 71 A LEU 72 n 72 LEU 72 A SER 73 n 73 SER 73 A VAL 74 n 74 VAL 74 A LEU 75 n 75 LEU 75 A LYS 76 n 76 LYS 76 A GLY 77 n 77 GLY 77 A GLU 78 n 78 GLU 78 A GLU 79 n 79 GLU 79 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A PRO 10 -66.76 76.14 1 A VAL 18 -29.72 -48.52 2 A GLN 3 -163.57 119.06 2 A PRO 10 -63.82 94.04 2 A VAL 18 -29.93 -51.34 2 A PRO 43 -85.87 34.07 2 A GLU 78 -140.83 36.30 3 A ASP 7 -71.21 -156.52 3 A PHE 14 -149.87 -49.03 3 A VAL 18 -29.96 -49.34 4 A PHE 14 -145.73 -79.89 4 A PRO 43 -93.16 44.80 5 A GLN 3 63.88 71.97 5 A GLU 8 -70.15 -73.32 5 A PHE 14 82.03 -15.63 5 A GLU 78 -158.59 44.92 6 A GLN 2 67.57 107.32 6 A PHE 14 -116.80 -70.50 6 A PRO 43 -92.99 35.35 7 A GLN 5 -72.67 -70.60 7 A GLN 6 -67.83 -178.39 7 A PHE 14 -138.95 -59.51 7 A PRO 43 -92.12 33.92 8 A GLN 6 -67.89 73.38 8 A PRO 12 -49.35 103.04 8 A GLU 78 -145.03 38.50 9 A PHE 14 -118.33 -73.27 9 A VAL 18 -29.96 -52.66 10 A PRO 4 -84.82 30.27 10 A PHE 14 -149.39 -50.87 10 A VAL 18 -29.99 -52.05 10 A GLU 78 -168.15 -60.47 11 A GLN 2 68.12 121.02 11 A VAL 18 -29.73 -54.52 11 A PRO 43 -91.50 33.83 12 A GLN 2 -122.44 -64.41 12 A PRO 4 -88.36 40.27 12 A GLN 6 -67.84 -157.27 12 A VAL 18 -29.35 -50.06 12 A PRO 43 -92.30 48.36 13 A GLN 2 -107.92 48.45 13 A GLN 3 -131.05 -70.03 13 A VAL 18 -29.54 -54.08 14 A PHE 14 -155.87 -55.40 14 A VAL 18 -29.58 -48.02 15 A PRO 4 -69.90 81.08 15 A VAL 18 -29.73 -45.94 15 A GLU 78 -174.19 -73.16 16 A PRO 10 -69.57 86.35 16 A PHE 14 -154.24 -51.75 16 A GLU 78 -172.66 -60.67 17 A VAL 18 -29.69 -48.96 17 A GLU 78 -142.83 36.50 18 A GLN 2 -113.66 50.04 18 A VAL 18 -29.79 -51.03 18 A PRO 43 -92.97 37.55 18 A GLU 78 -129.44 -71.45 19 A PRO 43 -91.14 38.59 20 A THR 13 -71.88 -87.00 20 A PHE 14 60.34 -83.32 20 A GLU 78 -131.27 -72.69 21 A GLN 6 -67.75 77.39 21 A PHE 14 -124.99 -57.02 21 A VAL 18 -29.59 -45.24 21 A PRO 43 -92.16 30.33 22 A GLU 78 -140.79 -68.29 23 A GLN 2 -155.38 44.51 23 A GLN 6 -67.73 82.77 23 A PHE 14 -151.54 -53.75 23 A VAL 18 -29.99 -45.55 23 A PRO 43 -93.64 42.70 24 A GLN 3 71.17 146.13 24 A PHE 14 -153.46 -59.10 24 A GLU 78 -150.91 38.33 25 A ASP 7 -71.03 -75.24 25 A PRO 43 -91.18 34.94 26 A PRO 12 -83.46 45.72 26 A VAL 18 -29.63 -45.39 27 A GLU 8 -70.24 -70.87 27 A PHE 14 -150.03 -63.00 27 A VAL 18 -29.66 -53.35 27 A PRO 43 -92.16 31.86 28 A GLN 3 60.83 65.54 28 A PHE 14 -103.39 -61.28 28 A VAL 18 -29.72 -46.55 28 A GLU 78 -175.09 -54.36 30 A GLN 5 -72.68 -161.45 30 A PHE 14 73.70 -69.08 30 A VAL 18 -29.94 -46.68 30 A PRO 43 -88.19 43.64 31 A GLU 8 -70.31 -74.32 31 A PHE 14 -125.02 -60.87 31 A VAL 18 -29.91 -53.77 31 A PRO 43 -93.37 35.95 32 A PRO 4 -90.22 30.78 32 A PHE 14 -142.18 -43.19 32 A VAL 18 -29.51 -49.18 32 A PRO 43 -91.98 31.77 33 A VAL 18 -29.90 -48.97 34 A GLN 2 -103.54 52.11 34 A GLN 6 -67.75 -73.07 34 A VAL 18 -29.62 -45.76 34 A PRO 43 -89.88 32.31 35 A PHE 14 -149.54 -67.22 35 A VAL 18 -29.83 -48.79 35 A PRO 43 -91.41 34.41 35 A GLU 78 -153.90 35.43 36 A GLN 6 -67.67 -74.59 36 A PHE 14 -107.21 -63.96 36 A GLU 78 -170.59 -65.62 37 A GLN 2 60.86 86.32 37 A PRO 10 -76.81 -168.10 37 A PRO 12 -70.05 -163.90 37 A THR 13 -71.84 -78.08 37 A PHE 14 69.89 -66.99 38 A GLN 2 -109.31 -66.79 38 A PHE 14 -122.27 -69.15 38 A PRO 43 -93.36 42.67 39 A GLN 3 63.75 70.78 39 A ASP 7 -71.08 -75.03 39 A VAL 18 -29.81 -46.96 39 A PRO 43 -91.24 37.88 39 A GLU 78 -173.22 -55.45 40 A PRO 4 -67.80 82.75 40 A GLN 6 -67.91 71.50 40 A PRO 12 -72.96 -168.98 40 A GLU 78 -151.06 33.25 42 A GLN 2 71.29 142.01 42 A THR 13 -71.91 -76.27 42 A PHE 14 65.44 -77.96 43 A PHE 14 -134.56 -56.67 43 A PRO 43 -91.31 40.57 43 A GLU 78 -146.93 38.93 44 A PHE 14 -166.42 -61.13 44 A VAL 18 -29.18 -50.31 44 A PRO 43 -93.08 37.03 44 A GLU 78 -103.86 -64.78 45 A PHE 14 -173.40 -61.92 46 A THR 13 -71.96 -71.67 46 A PHE 14 60.14 -87.89 46 A VAL 18 -29.56 -46.88 46 A GLU 78 -152.29 36.82 47 A GLN 6 -68.00 65.76 47 A PHE 14 -103.72 -64.97 47 A VAL 18 -29.99 -53.24 48 A GLN 6 -67.99 65.84 48 A TYR 41 -173.94 44.50 49 A GLN 3 60.66 60.71 49 A GLN 6 -67.81 -173.10 49 A THR 13 -71.92 -79.13 50 A GLN 3 -166.25 -63.20 50 A PHE 14 -130.48 -53.52 50 A GLU 78 -170.70 -68.00 51 A GLN 6 24.35 -101.62 51 A PRO 12 -68.52 -171.65 51 A PHE 14 -131.89 -58.97 51 A VAL 18 -29.98 -41.27 52 A LEU 42 67.73 67.56 52 A PRO 43 -95.14 -76.57 52 A GLU 78 -153.83 40.17 53 A PHE 14 -130.43 -71.14 53 A GLU 78 -172.79 -61.94 54 A GLN 3 -151.54 71.95 54 A VAL 18 -29.76 -46.99 54 A GLU 78 -172.45 -60.71 55 A GLN 6 -67.81 -175.44 55 A VAL 18 -29.75 -49.73 55 A PRO 43 -90.69 34.99 55 A GLU 78 -147.82 -62.82 56 A PHE 14 -160.73 -52.81 57 A GLN 2 68.09 108.21 57 A PRO 10 -67.00 80.88 57 A PRO 43 -92.97 36.83 57 A GLU 78 -149.80 -61.34 58 A GLN 3 -161.23 -62.07 58 A GLN 6 -67.72 -177.13 59 A PRO 4 -69.92 82.37 59 A GLN 6 -67.81 75.16 59 A GLU 78 -144.51 37.47 60 A VAL 18 -29.80 -44.32 60 A PRO 43 -92.81 36.52 61 A GLN 2 57.37 84.51 61 A GLN 3 -169.77 64.69 61 A GLN 5 -72.56 -74.07 61 A PRO 12 -66.82 91.33 61 A PHE 14 -143.10 -62.02 61 A GLU 78 -173.34 -55.13 62 A GLN 6 -67.81 -176.44 62 A PRO 12 -54.57 105.88 62 A PHE 14 -106.18 -66.24 63 A PRO 10 -72.52 -167.76 63 A PHE 14 -168.28 -65.55 63 A VAL 18 -29.52 -55.48 63 A GLU 78 -74.38 -74.31 64 A PHE 14 79.80 -43.84 64 A VAL 18 -29.45 -45.99 64 A PRO 43 -92.53 41.30 65 A GLN 6 -67.87 71.88 65 A PHE 14 -125.89 -63.89 65 A PRO 43 -92.67 40.31 65 A VAL 45 -27.78 -65.55 65 A GLU 78 -149.00 38.30 66 A LEU 42 41.93 72.27 66 A PRO 43 -92.75 -69.98 66 A GLU 78 -147.30 33.90 67 A GLN 6 -67.87 67.79 67 A PRO 12 -79.03 -159.42 67 A PHE 14 84.23 -49.53 67 A VAL 18 -29.97 -50.49 67 A PRO 43 -93.38 -62.34 67 A GLU 78 -74.50 -76.58 68 A GLN 3 -170.65 -61.13 68 A TYR 41 -65.78 -79.65 68 A LEU 42 174.37 -54.09 68 A VAL 45 -42.72 -77.00 APOLIPOPROTEIN C-II Global Structure and Dynamics of Human Apolipoprotein CII in Complex with Micelles: Evidence for increased mobility of the helix involved in the activation of lipoprotein lipase 1 N N A THR 16 A THR 16 HELX_P A GLU 38 A GLU 38 1 1 23 A VAL 45 A VAL 45 HELX_P A ALA 58 A ALA 58 1 2 14 A THR 64 A THR 64 HELX_P A VAL 74 A VAL 74 1 3 11 LIPID TRANSPORT APOCII, LPL, ACTIVATION MECHANISM, DOMAIN MOTION, SDS, MICELLE, GLOBAL STRUCTURE, LOCAL STRUCTURE, DYNAMICS, HELIX, LIPID TRANSPORT, LIPID DEGRADATION, CHYLOMICRON APC2_HUMAN UNP 1 P02655 23 101 1O8T 1 79 P02655 A 1 1 79 1 P 1